FDA: ADHD drug use should continue despite study on sudden death

06/16/2009 | Wall Street Journal, The

The FDA said children with attention-deficit/hyperactivity disorder should continue taking medications for their condition because there is no sufficient evidence that the drugs cause sudden death. The warning follows a study partly funded by the agency that cites 10 cases of sudden death in the patient group taking stimulants.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA